Blog
Why The Trade Desk Jumped 21% in July Before Tumbling in August
The Trade Desk (NASDAQ: TTD) stock tumbled on its second-quarter earnings report, but prior to that, the leading independent demand-side platform (DSP) had been building momentum through July into
Telos (TLS) Q2 2025 Earnings Call Transcript
Image source: The Motley Fool.
Monday, August 11, 2025 at 1:30 p.m. ET
Chief Executive Officer — John Wood
Source Fool.com
Telos Reports 26 Percent Revenue Growth
Telos(NASDAQ:TLS) reported second quarter 2025 results on August 11, 2025, delivering revenue of $36 million (up 26% year-over-year), adjusted EBITDA of $400,000 profit (versus loss guidance), and
Where Will Hims & Hers Be in 5 Years?
Hims and Hers (NYSE: HIMS) just posted a jaw-dropping 143% stock gain and a $586 million quarter -- but Wall Street says "hold." Between booming GLP-1 sales, Food and Drug Administration (FDA)
If You Missed Adobe or Canva, Watch This Stock Now
Figma (NYSE: FIG) just shocked the market with a 250% IPO surge -- but is the real story just getting started? This video dives into the overlooked catalysts and the risks and whether this design
U.S. Reportedly Taking 15% Cut of NVDA and AMD China Sales
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Advanced Micro Devices (NASDAQ: AMD). To learn more, check out the short video, consider subscribing, and click the
Should You Buy CoreWeave Stock Before Aug. 12?
In today's video, I discuss recent updates affecting CoreWeave (NASDAQ: CRWV). To learn more, check out the short video, consider subscribing, and click the special offer link below.
*Stock prices
BioCardia Narrows Loss in Fiscal Q2
BioCardia (NASDAQ:BCDA), a clinical-stage cell therapy company focused on treatments for heart disease, released its financial results for the second quarter of 2025 on August 11, 2025. The company
3 Hidden Dangers of Claiming Social Security at 70
If you've done any reading about when to claim Social Security, you've probably come across at least one article warning you about the dangers of claiming at age 62. Yes, you get more checks, but
Ceva Beats Estimates in Fiscal Q2
Ceva (NASDAQ:CEVA), a core supplier of chip design intellectual property (IP) for wireless connectivity and edge artificial intelligence (AI), reported its second quarter 2025 results on August 11
Great News for Nvidia Investors
In today's video, I discuss recent updates affecting Nvidia (NASDAQ: NVDA) and Intel (NASDAQ: INTC). To learn more, check out the short video, consider subscribing, and click the special offer link
American Strategic (NYC) Earnings Transcript
Image source: The Motley Fool.
Friday, Aug. 8, 2025 at 3:00 p.m. ET
Chief Executive Officer — Nicholas Schorsch, Jr.
Source Fool.com
Meet the Monster Stock that Continues to Crush the Market
Palantir (NASDAQ: PLTR), the data mining and analytics firm named after the all-seeing orbs from The Lord of the Rings, has been one of the market's hottest growth stocks. It went public via a
4 of the Most Undervalued Stocks in the Market Right Now
In today's video, I will look at four stocks that have seen meaningful pullbacks and now appear undervalued. In a stock market that has largely been viewed as overvalued, not all stocks are
Sonida Revenue Jumps 33 Percent in Q2
Sonida Senior Living (NYSE:SNDA), a senior housing owner and operator, reported second quarter results on August 11, 2025. The highlight was a sharply narrower GAAP net loss per share of $(0.16)
SoFi Just Posted Earnings. Here's What Stood Out
Banking disruptor SoFi (NASDAQ: SOFI) recently reported its second-quarter earnings, and the numbers look strong all around. Asset quality is improving, customers are coming into the ecosystem at a
Protara Beats Q2 Loss Estimates
Protara Therapeutics (NASDAQ:TARA), a clinical-stage biotechnology company focused on treatments for cancer and rare diseases, reported its second quarter 2025 financial results on August 11, 2025
Aptevo Reports 85% Remission in Q2
Aptevo Therapeutics (NASDAQ:APVO), a clinical-stage immuno-oncology company focusing on innovative antibody therapies for cancer, reported second quarter results on August 11, 2025, covering the
4dMT Revenue Jumps 200 Percent in Q2
4d Molecular Therapeutics (NASDAQ:FDMT), a clinical-stage genetic medicines company specializing in targeted gene therapies, reported financial results for the second quarter of fiscal 2025 on
This Dark-Horse AI Stock Has Great News for Investors
Appian (NASDAQ: APPN) has long been a leader in low-code and automation technology, allowing its customers to quickly build powerful apps that automate things like insurance claims processing or
Motorcar Parts Q1 Revenue Up 11 Percent
Motorcar Parts Of America (NASDAQ:MPAA), a supplier of replacement parts and electrical diagnostic equipment for vehicles, reported its earnings for the fiscal first quarter (ended June 30, 2025) on
ArriVent Posts Wider Loss in Fiscal Q2
ArriVent BioPharma (NASDAQ:AVBP), a clinical-stage oncology company, reported its second quarter 2025 earnings on August 11, 2025. The most important update was a wider net loss than expected--the
Up 23% to 132%, There's Still Time to Buy These 3 Stocks
We're more than halfway through 2025, and so far, it's shaping up to be another solid year for the stock market. As of this writing, the S&P 500, Nasdaq Composite, and Dow Jones Industrial Average
Do NuScale Power and Oklo Have a New Opportunity That's Out of This World?
With few exceptions, nuclear energy stocks have provided stellar returns in 2025. From new collaborations that small modular reactor (SMR) makers like NuScale Power (NYSE: SMR) and Oklo (NYSE: OKLO)
L.b. Foster Posts 51% EBITDA Jump in Q2
L.b. Foster (NASDAQ:FSTR), a key player in infrastructure and technology-driven solutions for rail and construction markets, reported earnings for Q2 2025 on August 11, 2025. The most important